pHOTREXA
Drug
Avedro Inc.
Total Payments
$176,390
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $176,390 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $176,390 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 308 | Avedro Inc. | $176,390 | 0 |
Top Doctors Receiving Payments for pHOTREXA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Mclean, VA | $176,390 | 1 |
Ad
Manufacturing Companies
- Avedro Inc. $176,390
Product Information
- Type Drug
- Total Payments $176,390
- Total Doctors 0
- Transactions 1
About pHOTREXA
pHOTREXA is a drug associated with $176,390 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Avedro Inc..
Payment data is available from 2019 to 2019. In 2019, $176,390 was paid across 1 transactions to 0 doctors.
The most common payment nature for pHOTREXA is "Unspecified" ($176,390, 100.0% of total).
pHOTREXA is associated with 1 research study, including "308" ($176,390).